BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 12398841)

  • 41. Facioscapulohumeral Muscular Dystrophy.
    DeSimone AM; Pakula A; Lek A; Emerson CP
    Compr Physiol; 2017 Sep; 7(4):1229-1279. PubMed ID: 28915324
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Facioscapulohumeral muscular dystrophy and limb-girdle muscular dystrophy: "double trouble" overlapping syndrome?
    Simeoni S; Russo V; Gigli GL; Scalise A
    J Neurol Sci; 2015 Jan; 348(1-2):292-3. PubMed ID: 25528007
    [No Abstract]   [Full Text] [Related]  

  • 43. [Progress in researches on the molecular genetics of facioscapulohumeral muscular dystrophy].
    Su Q; Zhang C
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2001 Oct; 18(5):398-401. PubMed ID: 11592052
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A severe case of facioscapulohumeral muscular dystrophy (FSHD) with some uncommon clinical features and a short 4q35 fragment.
    Dorobek M; Kabzińska D
    Eur J Paediatr Neurol; 2004; 8(6):313-6. PubMed ID: 15542386
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Diagnostic image (53). Facioscapulohumeral muscle dystrophy].
    de Visser M
    Ned Tijdschr Geneeskd; 2001 Sep; 145(35):1690. PubMed ID: 11561486
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Phenotypic-genotypic correlation will assist genetic counseling in 4q35-facioscapulohumeral muscular dystrophy.
    Lunt PW; Jardine PE; Koch M; Maynard J; Osborn M; Williams M; Harper PS; Upadhyaya M
    Muscle Nerve Suppl; 1995; (2):S103-9. PubMed ID: 23573595
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Facioscapulohumeral muscular dystrophy with EcoRI/BlnI fragment size of more than 32 kb.
    Vielhaber S; Jakubiczka S; Schröder JM; Sailer M; Feistner H; Heinze HJ; Wieacker P; Bettecken T
    Muscle Nerve; 2002 Apr; 25(4):540-8. PubMed ID: 11932972
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Genotype-phenotype study in an FSHD family with a proximal deletion encompassing p13E-11 and D4Z4.
    Deak KL; Lemmers RJ; Stajich JM; Klooster R; Tawil R; Frants RR; Speer MC; van der Maarel SM; Gilbert JR
    Neurology; 2007 Feb; 68(8):578-82. PubMed ID: 17229919
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical and genetic features of patients with facial-sparing facioscapulohumeral muscular dystrophy.
    He JJ; Lin XD; Lin F; Xu GR; Xu LQ; Hu W; Wang DN; Lin HX; Lin MT; Wang N; Wang ZQ
    Eur J Neurol; 2018 Feb; 25(2):356-364. PubMed ID: 29112784
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Low D4Z4 copy number and gender difference in Korean patients with facioscapulohumeral muscular dystrophy type 1.
    Park HJ; Hong JM; Lee JH; Lee HS; Shin HY; Kim SM; Ki CS; Lee JH; Choi YC
    Neuromuscul Disord; 2015 Nov; 25(11):859-64. PubMed ID: 26319123
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Rapid and accurate diagnosis of facioscapulohumeral muscular dystrophy.
    Goto K; Nishino I; Hayashi YK
    Neuromuscul Disord; 2006 Apr; 16(4):256-61. PubMed ID: 16545566
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pearls in the junk: dissecting the molecular pathogenesis of facioscapulohumeral muscular dystrophy.
    Dmitriev P; Lipinski M; Vassetzky YS
    Neuromuscul Disord; 2009 Jan; 19(1):17-20. PubMed ID: 18974002
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Molecular diagnosis of facioscapulohumeral muscular dystrophy.
    Upadhyaya M; Cooper DN
    Expert Rev Mol Diagn; 2002 Mar; 2(2):160-71. PubMed ID: 11962336
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Becker's muscular dystrophy aggravating facioscapulohumeral muscular dystrophy--double trouble as an explanation for an atypical phenotype.
    Rudnik-Schöneborn S; Weis J; Kress W; Häusler M; Zerres K
    Neuromuscul Disord; 2008 Nov; 18(11):881-5. PubMed ID: 18684626
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Facioscapulohumeral muscular dystrophy can be a cause of isolated childhood cognitive dysfunction.
    Hobson-Webb LD; Caress JB
    J Child Neurol; 2006 Mar; 21(3):252-3. PubMed ID: 16901430
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Molecular genetics of facioscapulohumeral muscular dystrophy (FSHD).
    Fisher J; Upadhyaya M
    Neuromuscul Disord; 1997 Jan; 7(1):55-62. PubMed ID: 9132141
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Facioscapulohumeral muscle dystrophy and heart disease].
    Emmrich P; Ogunlade V; Gradistanac T; Daneschnejad S; Koch MC; Schober R
    Z Kardiol; 2005 May; 94(5):348-54. PubMed ID: 15868364
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Diagnostic challenges in facioscapulohumeral muscular dystrophy.
    Sacconi S; Salviati L; Bourget I; Figarella D; Péréon Y; Lemmers R; van der Maarel S; Desnuelle C
    Neurology; 2006 Oct; 67(8):1464-6. PubMed ID: 17060574
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Molecular combing reveals complex 4q35 rearrangements in Facioscapulohumeral dystrophy.
    Nguyen K; Puppo F; Roche S; Gaillard MC; Chaix C; Lagarde A; Pierret M; Vovan C; Olschwang S; Salort-Campana E; Attarian S; Bartoli M; Bernard R; Magdinier F; Levy N
    Hum Mutat; 2017 Oct; 38(10):1432-1441. PubMed ID: 28744936
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Miyoshi-type distal muscular dystrophy. Clinical spectrum in 24 Dutch patients.
    Linssen WH; Notermans NC; Van der Graaf Y; Wokke JH; Van Doorn PA; Höweler CJ; Busch HF; De Jager AE; De Visser M
    Brain; 1997 Nov; 120 ( Pt 11)():1989-96. PubMed ID: 9397016
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.